Tag: terumo aortic

surgical graft

Terumo Aortic announces launch of landmark global surgical graft study

Terumo Aortic has announced the launch of the company’s global surgical graft study known as PANTHER. This study is a prospective and retrospective, multicentre,...

Terumo Aortic announces first implant of landmark thoracoabdominal hybrid device

Terumo Aortic has announced the successful implantation of the company’s first custom-made thoracoabdominal hybrid device to treat thoracoabdominal aortic disease. The world’s first thoracoabdominal repair...

Terumo Aortic announces first commercial implants of RelayPro endovascular device in...

Following the recent approval by the US Food and Drug Administration (FDA) of the RelayPro thoracic stent graft system for the treatment of patients...

Vascular News’ top 10 most popular stories of August 2021

Research presented at the Society for Vascular Surgery’s Vascular Annual Meeting (SVS VAM 2021; 18–21 August, San Diego, USA and online)—including new VOYAGER PAD...

Terumo Aortic announces US FDA approval for RelayPro endovascular device

Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of its RelayPro thoracic stent-graft system for sale in...
Treo

Primary endpoint results from Treo pivotal study published

Following recent approval by the US Food and Drug Administration (FDA) of the Treo abdominal aortic stent graft system for the treatment of patients...

RelayPro US transection pivotal study completes enrolment

Terumo Aortic has announced completion of enrolment of the RelayPro traumatic injury (RelayPro-T) investigational device exemption (IDE) study in the USA. RelayPro is a...

Terumo Aortic announces mid-term results with real-world use of the RelayPlus...

Terumo Aortic has announced the midterm results from the RelayPlus thoracic stent graft system post-approval study, revealing low operative mortality and morbidity—supporting its use...
Treo

Terumo Aortic announces FDA approval for Treo endovascular device

Terumo Aortic has announced that the US Food and Drug Administration (FDA) has granted approval of the Treo abdominal aortic stent-graft system for sale...

Terumo Aortic announces US FDA breakthrough device designation for Thoraflex Hybrid...

Terumo Aortic today announced that the US Food and Drug Administration (FDA) has granted breakthrough device designation for its Thoraflex Hybrid stented device for...
TiGER Principal Investigator, Vincent Riambau

Terumo Aortic announces launch of industry-first global endovascular registry

Terumo Aortic has announced the launch of the company’s global endovascular registry known as TiGER (Terumo Aortic Global Endovascular Registry). TiGER is a global, prospective,...

Terumo Aortic announces completion of enrolment of RelayPro US pivotal study

Terumo Aortic has announced the completion of enrolment of the RelayPro pivotal study in the USA. RelayPro is a low profile, next generation thoracic...

Terumo Aortic acquires Serom Medical Technology

Terumo Aortic has announced the acquisition of Serom Medical Technology S.r.l. by Vascutek Ltd and the subsequent merger with Bolton Medical S.r.l. in Italy. Serom...

RelayBranch early feasibility study begins enrolment

The first two patients have been successfully enrolled in the RelayBranch Early Feasibility Study. This trial will assess the safety and efficacy of the...

CX 2018: Terumo Aortic launches RelayPro thoracic stent graft in Europe

Terumo Aortic have announced the European limited market release of the RelayPro thoracic stent graft system at the 2018 Charing Cross Symposium (CX; 24–27...

Vascutek and Bolton Medical merge as “Terumo Aortic”

Vascutek and Bolton Medical, subsidiaries of Terumo Corporation of Japan, have combined into Terumo Aortic. Combining the aortic companies into a single business, Terumo...